Cargando…
Epigenetic down‐regulation of microRNA‐126 in scleroderma endothelial cells is associated with impaired responses to VEGF and defective angiogenesis
Impaired angiogenesis in scleroderma (SSc) is a critical component of SSc pathology. MicroRNA‐126 (miR‐126) is expressed in endothelial cells (MVECs) where it regulates VEGF responses by repressing the negative regulators of VEGF, including the sprouty‐related protein‐1 (SPRED1), and phosphoinositid...
Autores principales: | Wang, Yongqing, Sun, John, Kahaleh, Bashar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278107/ https://www.ncbi.nlm.nih.gov/pubmed/34137496 http://dx.doi.org/10.1111/jcmm.16727 |
Ejemplares similares
-
Epigenetic repression of bone morphogenetic protein receptor II expression in scleroderma
por: Wang, Yongqing, et al.
Publicado: (2013) -
Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis
por: van Solingen, Coen, et al.
Publicado: (2009) -
MicroRNA-126 and VEGF enhance the function of endothelial progenitor cells in acute myocardial infarction
por: Zhang, Ying, et al.
Publicado: (2022) -
MicroRNA-126 inhibits tumor proliferation and angiogenesis of hepatocellular carcinoma by down-regulating EGFL7 expression
por: Hu, Ming-Hua, et al.
Publicado: (2016) -
Correction: MicroRNA-126 inhibits tumor proliferation and angiogenesis of hepatocellular carcinoma by down-regulating EGFL7 expression
por: Hu, Ming-Hua, et al.
Publicado: (2021)